CHESTERFIELD, Mo.–(BUSINESS WIRE)–As a pioneer in the eye health, nutrition, and performance space, EyePromise continues to cultivate powerful partnerships within sports.
Author: Business Wire
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
GENEVA–(BUSINESS WIRE)–Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
GENEVA–(BUSINESS WIRE)–Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
Harrow Announces First Quarter 2024 Financial Results
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the first quarter ended March 31, 2024. The Company also posted its first quarter Letter to Stockholders …
NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces the introduction of an expanded line of Avenova® product bundles …
$6.1 Billion Optometry Equipment (OCT, Ophthalmoscope, Autorefractor, Tonometer, Slitlamp, Wavefront Analyzer) Market Analysis – Global Forecast to 2029 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Optometry Equipment Market by Type (OCT, Ophthalmoscope, Autorefractor, Tonometer, Slitlamp, Wavefront Analyzer), Application (General Examination, Cataract, Glaucoma), End User (Eye Clinics, Hospitals), and Region …
Viridian Therapeutics to Participate in Upcoming May Investor Conferences
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management will …
Topcon Healthcare Inc. (THI) Partners with Microsoft to Deliver AI-Powered ‘Healthcare from the Eye’ Through a Connected Healthcare Platform
OAKLAND, N.J.–(BUSINESS WIRE)– #TopconHealthcare–Topcon Healthcare Inc. (THI) announces a partnership with Microsoft Corporation to deliver AI-powered ‘Healthcare from the Eye’ solutions to improve healthcare access, cost, and quality. A cloud-based…
LENSAR Reports First Quarter 2024 Results and Provides Business Update
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quart…
Warby Parker Announces First Quarter 2024 Results
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (“Warby Parker” or the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the first quarter ended March 31, 2024. “We entered 2024 …
Alcon Announces Results of 2024 Annual General Meeting
GENEVA–(BUSINESS WIRE)–Alcon Announces Results of 2024 Annual General Meeting
Largest Prospective Study to Date Further Supports Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with DecisionDx-UM Class Result
FRIENDSWOOD, Texas–(BUSINESS WIRE)—- $CSTL #COOG–Castle announced data supporting the utility of the PRAME biomarker as a risk refinement tool when considered in the context of a DecisionDx-UM result
Alcon Announces Results of 2024 Annual General Meeting
GENEVA–(BUSINESS WIRE)–Alcon Announces Results of 2024 Annual General Meeting
OneLegacy Inspires Hollywood Announces First Three Board Members: Actor Danny Trejo, Showrunner Carol Barbee and Hip-Hop Artist Freeway
LOS ANGELES–(BUSINESS WIRE)–OneLegacy Inspires Hollywood, formerly known as Donate Life Hollywood, announces the first three board members of the revamped initiative: Danny Trejo, Carol Barbee and Freeway. OneLegacy Inspires Hollywood is a project of…
AdvanCell Expands Leadership Team with the Appointment of Christopher Horvath, MS MBA, as Chief Commercial Officer & Chief Operating Officer and Gary Li, PhD, as Chief Strategy Officer
SYDNEY–(BUSINESS WIRE)–AdvanCell, a clinical-stage radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for patients with cancer, today announced the appointment of two senior management team members. Chris Horvath, MS, MBA -…
Aldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced enrollm…
Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today reported recent business highlights and fi…
National Vision Holdings, Inc. Reports First Quarter 2024 Financial Results
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the first quarter ended March 30, 2024. “We delivered first quarter results in line with our expect…
STAAR Surgical Reports First Quarter 2024 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: K), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today reported financial resul…
STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announces another mil…